Associated Papers
Compound heterozygous NFKB1 missense variants in cis associated with immunodeficiency.
Fliegauf M et al.
Clinical Immunology (orlando, Fla.), 2026
Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas.
Gallardo F et al.
Cancers, 2022
Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma.
Nagel S et al.
Biomedicines, 2022
Detrimental NFKB1 missense variants affecting the Rel-homology domain of p105/p50.
Fliegauf M et al.
Frontiers in Immunology, 2022
36105815 (PubMed )
Supplement: DataSheet_1.pdf
Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency.
Li J et al.
The Journal of Experimental Medicine, 2021
Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity.
Park J et al.
Blood, 2021
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.
Dufva O et al.
Nature Communications, 2018
29674644 (PubMed )
Supplement: 41467_2018_3987_MOESM5_ESM.xlsx › ANKL14
Select a paper to view details